Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Dec 24;99(26):16666-71.
doi: 10.1073/pnas.262672699. Epub 2002 Dec 16.

Z-DNA-binding proteins can act as potent effectors of gene expression in vivo

Affiliations

Z-DNA-binding proteins can act as potent effectors of gene expression in vivo

Doo-Byoung Oh et al. Proc Natl Acad Sci U S A. .

Abstract

The role of Z-DNA-binding proteins in vivo is explored in yeast. A conformation-specific yeast one-hybrid system is made in which formation of Z-DNA is studied near a minimal promoter site where it can be stabilized by negative supercoiling in addition to protein binding. Experiments were carried out with a Z-DNA-binding protein domain from the editing enzyme, double-stranded RNA adenosine deaminase 1. In the one-hybrid system, the reporter gene is activated when a Z-DNA-specific binding domain is fused with an activation domain and expressed in vivo. Significantly, it was found that even in the absence of the activation domain there is substantial transcription of the reporter gene if the Z-DNA-binding protein is expressed in the cell. This result suggests that Z-DNA formation in the promoter region induced or stabilized by a Z-DNA-binding protein can act as a cis-element in gene regulation. Related results have been found recently when the human chromatin-remodeling system converts a segment of DNA in the promoter region of the human colony-stimulating factor 1 gene into the left-handed Z-conformation.

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
Schematic representation of reporter vectors. For reporter vector construction, bait sequences of various repeats of (dC-dG) are inserted between the reporter gene (LacZ) and the URA3 gene. Two orientations of the selection marker gene, URA3, are used for creating favorable (A, opposite or Op) or unfavorable (B, same or Sm) conditions for Z-DNA formation. In the pLacZcOp vector, the orientation of URA3 transcription is opposite to that of the LacZ-reporter gene. In contrast, transcriptions from both URA3 and LacZ have the same orientation in the pLacZcSm vector. As shown diagrammatically with pLacZcOp, transcription of the LacZ-reporter gene is activated when hZαADAR carrying an AD binds to Z-DNA. The Zα-AD hybrid fusion is expressed from an independent vector, pACT2-Zα.
Fig 2.
Fig 2.
The Zα-AD fusion protein activates transcription of the LacZ-reporter gene by binding to upstream Z-DNA forming bait sequences. (A) Units of β-galactosidase activity made as a function of n, the number of (dC-dG) repeats in the vector; n = 0 represents a control sequence. pLacZcOp vectors were transfected into yeast either without (None) or with pACT2 or the pACT2-Zα expression vectors containing hZαADAR. β-galactosidase activity measured by the quantitative ONPG assay shows that an increasing number of repeats of (dC-dG) in the bait sequences give rise to an increase of reporter gene activation. Three measurements were made at each point. (B) Comparison of activation of the LacZ gene by the Zα-AD fusion protein in different reporter vectors, pLacZcOp and pLacZcSm. The numbers above the bars represent the fold increase of the enzyme activity in pLacZcOp compared to pLacZcSm. The differences are significant with (dC-dG)4 and (dC-dG)5 but not with (dC-dG)9 and (dC-dG)12.
Fig 3.
Fig 3.
Analysis of the Z-DNA-binding activities of Zα, Zβ, Za′b, Zab, and Zaa by using lacZ-reporter gene activation. Zα, Zβ, and Zab all come from human ADAR1 (17). In Zaa, the Zβ domain of Zab is removed and Zα replaces it (18). Za′b has mutations in Zα of Zab as described (12). (A) Vectors containing an AD fused to nothing (pACT2) or to various human Zα constructs from human ADAR1 (pACT2-Zβ, -Zα, -Zab, -Za′b, and –Zaa) were cotransfected into yeast with pLacZcOp- (dC-dG)n (where n = 4, 5, 9, and 12). β-galactosidase activities were determined by quantitative ONPG assay. In general, background enzyme activity (with pACT2 transfection) increases as longer repeats of (dC-dG) are used in bait sequences. The hZαADAR-containing peptides (hZαADAR, hZabADAR, and hZaaADAR) show high levels of enzyme activity. However, hZβADAR and hZa′bADAR do not show significant activity above the controls. (B) Yeast cells were transformed with recombinant pACT2-based vectors and either pLacZcOp-(dC-dG)4 or pLacZcSm-(dC-dG)4 and plated onto selective medium containing X-gal, a β-galactosidase substrate. Development of a blue color indicates β-galactosidase activity hydrolyzing X-gal, as described in Materials and Methods. Higher levels of β-galactosidase activity were shown in pLacZcOp-(dC-dG)4 than in pLacZcSm-(dC-dG)4.
Fig 4.
Fig 4.
Zα by itself activates transcription of the reporter. Expression of Zα alone without the Gal4 AD was examined. pGNA-Zα expresses Zα with the simian virus 40 T-antigen nuclear localization signal at the N terminus (described in Materials and Methods). (A) Experiments were performed with different pLacZcOp-(dC-dG)n reporters. hZαADAR expression increases β-galactosidase activity significantly as stretches of dC-dG become longer. Activation on X-gal plates of the reporter gene LacZ by the pGNA plasmid alone or expressing various proteins; pGNA-Zβ, pGNA-Zα, and pGNA-Zaa in pLacZcOp-(dC-dG)n or pLacZcSm-(dC-dG)n when n = 5 (B) or n = 9 (C). The contribution of negative supercoiling to Z-DNA formation because of opposite or same orientations is apparent in B, where n = 5. The great tendency of longer stretches to form Z-DNA where n = 9 swamps out the smaller distinction between opposite and same orientation.

Similar articles

Cited by

References

    1. Liu J., Wilson, T. E., Milbrandt, J. & Johnston, M. (1993) Methods 5, 125-137.
    1. Allen J. B., Walberg, M. W., Edwards, M. C. & Elledge, S. J. (1995) Trends Biochem. Sci. 20, 511-516. - PubMed
    1. Wang A. H., Quigley, G. J., Kolpak, F. J., Crawford, J. L., van Boom, J. H., van der Marel, G. & Rich, A. (1979) Nature 282, 680-686. - PubMed
    1. Rich A., Nordheim, A. & Wang, A. H. (1984) Annu. Rev. Biochem. 53, 791-846. - PubMed
    1. Peck L. J., Nordheim, A., Rich, A. & Wang, J. C. (1982) Proc. Natl. Acad. Sci. USA 79, 4560-4564. - PMC - PubMed

Publication types